BCYC Q3 2021 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena

BCYCBicycle Therapeutics plc

$360M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+12.8% YoY

Gross Profit

$4M100.0% margin

Operating Income

-$14M-329.9% margin

Net Income

-$15M-338.7% margin

EPS (Diluted)

$-0.59

QoQ Revenue Growth

+142.7%

Cash Flow

Operating Cash Flow

$22M

Free Cash Flow

$22M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$281M

Total Liabilities

$111M

Stockholders' Equity

$171M

Cash & Equivalents

$260M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$4M	+12.8%
Gross Profit	$4M	$4M	+12.8%
Operating Income	-$14M	-$11M	-33.9%
Net Income	-$15M	-$10M	-44.8%

Revenue Segments

Target 6 Material Right

$1M100%